Your session is about to expire
← Back to Search
Livfresh Dental Gel for Gum Disease
Study Summary
This trial will study whether Livionex Dental Gel, used at home, can reduce pocket depth beyond what is achievable with the current standard of care (scaling and root planing).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe untreated tooth decay.I need medication before any dental work due to a medical condition.You have at least 20 BOP sites.I am 18 years old or older.I haven't had surgery for gum disease in the last year.I am willing to only use a manual toothbrush during the study.I have a dental infection that needs treatment during the study.I have a disease affecting my mouth's soft or hard tissues.I have at least 20 natural teeth, not counting wisdom teeth.I do not have severe systemic diseases or conditions that would prevent proper oral care.I am 18 years old or older.I have health conditions or take medications that could affect my gum health.My gum disease is severe (Stage IV or Grade C).I have moderate to severe gum disease with deep pockets in at least 4 teeth.You brush your teeth too much or use special devices to clean between your teeth more than twice a day.You are available for the duration of the study.\nI have at least 20 natural teeth, not counting wisdom teeth.You have braces or other orthodontic appliances on your teeth.You have had an allergic reaction to any ingredient found in the toothpaste being tested or the regular toothpaste.I have moderate to severe gum disease with deep pockets in at least 4 teeth.I haven't taken antibiotics for gum disease or used anti-inflammatory drugs regularly in the last month.
- Group 1: Scaling and Root Planing (SRP) + Livfresh Dental Gel (LDG)
- Group 2: Scaling and Root Planing (SRP) + standard fluoride dentifrice
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial welcoming elderly participants?
"This research is open to any participants under 85 years old and above the age of legal majority."
What is the estimated sample size for this research endeavor?
"Yes, the information on clinicaltrials.gov reveals that this trial is actively searching for enrollees. It was initially launched on October 14th 2022 and its most recent update was made on October 31st 2022. 76 participants are required from a single medical site."
Does this trial still accept new enrollees?
"Affirmative. Clinicaltrials.gov data confirms that this research project, which was originally publicized on October 14th 2022, is still calling for recruits. Approximately 76 patients need to be recruited from 1 medical centre."
To whom does eligibility requirements for this experiment apply?
"This trial is seeking 76 male or female participants aged 18 to 85 with dental plaque. To be eligible, candidates must have a minimum of 20 teeth, excluding third molars, and evidence of periodontitis (Stage II or III Grade B) on at least 4 of them. Additionally they are required to provide written consent and not use antibiotics for periodontal disease nor chronic anti-inflammatory drugs in the month before Baseline or during the study duration. Furthermore subjects need to commit to comply with all follow up visits as described by protocol and be available for telephone contact throughout the study course."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger